Herpes simplex virus

Infections of the Central Nervous System: Fourth Edition

Volumn , Issue , 2014, Pages

  Whitley, Richard J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957859473     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (188)

1. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002;359:507-513.
2. Mettler C. History of Medicine. New York: McGraw-Hill (Blakiston); 1947.
3. Astruc J. De Morbis Venereis Libri Sex. Paris: G. Cavelier; 1736.
4. Gruter W. Das herpesvirus, seine atiologische und klinische bedeutung. Munch Med Wschr. 1924;71:1058.
5. Goodpasture E. The axis-cylinders of peripheral nerves as portals of entry to the central nervous system for the virus of herpes simplex encephalitis in man. Am J Pathol. 1925;1:11-28.
6. Mathewson Commission. Epidemic Encephalitis: Etiology, Epidemiology, Treatment. Report of a Survey by the Mathewson Commission. New York: Columbia University Press; 1929.
7. Smith MG, Lennette EH, Reames HR. Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol. 1941;17:55-68.
8. Zarafonetis CJD, Smodel MC, Adams JW, et al. Fatal herpes simplex encephalitis in man. Am J Pathol. 1944;20(3):429-445.
9. Nahmias AJ, Dowdle WR. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol. 1968;10:110-159.
10. Bernstein DI, Bellamy AR, Hook EW III, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344-351.
11. Roizman B, Knipe D, Whitley R. Herpes simplex virus. In: Knipe D, Howley D, Griffin DE, et al, eds. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
12. Whitley RJ, Roizman B. Herpes simplex viruses. In: Whitley RJ, Richman D, Hayden F, eds. Clinical Virology. 3rd ed. Washington, DC: ASM Publishing; 2009.
13. Boos J, Esiri MM. Sporadic encephalitis. In: Viral Encephalitis: Pathology, Diagnosis and Management. Boston: Blackwell Scientific Publishers. 1986; 55-93.
14. Boos J, Kim JH. Biopsy histopathology in herpes simplex encephalitis and in encephalitis of undefined etiology. Yale J Bio Med. 1984;57:751-755.
15. Kapur N, Barker S, Burrows EH, et al. Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile. J Neurol Neurosurg Psychiatry. 1994;57:1334-1342.
16. Garcia JH, Colon LE, Whitley RJ, et al. Diagnosis of viral encephalitis by brain biopsy. Semin Diagn Pathol. 1984;1:71-81.
17. Hill TJ. Herpes simplex virus latency. In: Roizman B, ed. The Herpesviruses. New York: Plenum Publishing; 1985:175-240.
18. Cook ML, Stevens JG. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence of intra-axonal transport of infection. Infect Immun. 1973;7:272-288.
19. Roizman B, Whitley RJ. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol. 2013;67:355-374.
20. Baringer JR. The biology of herpes simplex virus infection in humans. Surv Ophthalmol. 1976;21:171.
21. Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med. 1973;288:648-650.
22. Bastian FO, Rabson AS, Yee CL. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972;178:306.
23. Nesburn AB, Cook ML, Stevens JG. Latent herpes simplex virus isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol. 1972;88:412-417.
24. Stevens JG, Cook ML. Latent herpes simplex virus in spinal ganglia. Science. 1971;173:843-845.
25. Stevens JG, Cook ML. Latent herpes simplex virus in sensory ganglia. Perspect Virol. 1974;8:171.
26. Warren KG, Brown SM, Wrobelwska A, et al. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med. 1978;298:1068-1069.
27. Cushing H. Surgical aspects of major neuralgia of trigeminal nerve: report of 20 cases of operation upon the Gasserian ganglion with anatomic and physiologic notes on the consequences of its removal. JAMA. 1905;44: 773-3379, 860-865, 920-929, 1002-1008.
28. Goodpasture EW. Herpetic infections with special reference to involvement of the nervous system. Medicine. 1929;8:223-243.
29. Carlton CA, Kilbourne ED. Activation of latent herpes simplex by trigeminal sensory-root section. N Engl J Med. 1952;246:172.
30. Pazin GJ, Ho M, Jannetta PJ. Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis. 1978;138: 405-409.
31. Pazin GJ, Armstrong JA, Lam MT, et al. Prevention of reactivation of herpes simplex virus infection by human leukocyte interferon after operation on the trigeminal route. N Engl J Med. 1979;301:225-230.
32. Ellison SA, Carlton CA, Rose HM. Studies of recurrent herpes simplex infections following section of the trigeminal nerve. J Infect Dis. 1959;105:161-167.
33. Walz MA, Price RW, Nortkins AL. Latent ganglionic infections with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science. 1974;184:1185-1187.
34. Rector JT, Lausch RN, Oakes JE. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun. 1982;38:168-174.
35. Segal AL, Katcher AH, Brightman VJ, et al. Recurrent herpes labialis, recurrent aphthous ulcers and the menstrual cycles. J Dent Res. 1974;53: 797-803.
36. Baringer JR. Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med. 1974;291:828-830.
37. Cabrera CV, Wholenberg C, Openshaw H, et al. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature. 1980;288:288-290.
38. Fraser NW, Lawrence WC, Wroblewska A, et al. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci. 1981;78:6461-6465.
39. Warren KG, Gilden DH, Brown SM. Isolation of herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet. 1977;2:637-639.
40. Nahmias AJ, Whitley RJ, Visintine AN, et al. Herpes simplex encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982;145:829-836.
41. Whitley RJ, Lakeman AD, Nahmias AJ, et al. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982;307:1060-1062.
42. Johnson RT, Olson LC, Buescher EL. Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis. Arch Neurol. 1968;18(3):260-264.
43. Dinn JJ. Transolfactory spread of virus in herpes simplex encephalitis. Br Med J. 1980;281:1392.
44. Ojeda VJ, Archer M, Robertson TA, et al. Necropsy study of olfactory portal of entry in herpes simplex encephalitis. Med J Aust. 1983;1:79-81.
45. Twomey JA, Barker CM, Robinson G, et al. Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psych. 1979;42:983-987.
46. Schlitt M, Lakeman FD, Wilson ER, et al. A rabbit model of focal herpes simplex encephalitis. J Infect Dis. 1986;153:732-735.
47. Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J Infect Dis. 1986;153:721-731.
48. Rock DL, Frasher NW. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 1983;302:523-531.
49. Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis. Ann Neurol. 1979;5:2-5.
50. Griffith JR, Kibrick S, Dodge PR, et al. Experimental herpes simplex encephalitis: electroencephalographic, clinical, virologic, and pathologic observations in the rabbit. Electroencephalogr Clin Neurophysiol. 1967;23: 263-267.
51. Guo Y, Audry M, Ciancanelli M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med. 2011;208(10):2083-2098.
52. Black FL. Infectious diseases in primitive societies. Science. 1975;187: 515-518.
53. Glezen WP, Fernald GW, Lohr JA. Acute respiratory disease of university students with special references to the etiologic role of herpesvirus hominis. Am J Epidemiol. 1975;101:111-121.
54. Burnet FM, Williams SW. Herpes simplex: new point of view. Med J Aust. 1939;1:637-640.
55. Dodd K, Johnston LM, Buddingh GJ. Herpetic stomatitis. J Pediatr. 1938;12:95.
56. Buddingh GH, Schrum DI, Lanier JC, et al. Studies of the natural history of herpes simplex infections. Pediatrics. 1953;11:595-610.
57. Juretic M. Natural history of herpetic infection. Helv Pediatr Acta. 1966;21:356.
58. Cesario TC, Poland JD, Wulff H, et al. Six years experiences with herpes simplex virus in a children's home. Am J Epidemiol. 1969;90:416-422.
59. Douglas RG Jr, Couch RB. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970;104:289-295.
60. Kloene W, Bang FB, Chakroborty SM, et al. A two-year respiratory virus survey in four villages in West Bengal, India. Am J Epidemiol. 1970;92: 307-320.
61. Lindgren KM, Douglas RG Jr, Couch RB. Significance of herpesvirus hominis in respiratory secretions of man. N Engl J Med. 1968;276:517-523.
62. Stern H, Elek SD, Miller DM, et al. Herpetic whitlow, a form of cross-infection in hospitals. Lancet. 1959;2:871.
63. Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol. 1976;41:498-507.
64. Scott TF, Steigman AJ, Convey JH. Acute infectious gingivostomatitis: etiology, epidemiology, and clinical pictures of a common disorder caused by the virus of herpes simplex. JAMA. 1941;117:999.
65. Templeton AC. Generalized herpes simplex in malnourished children. J Clin Pathol. 1970;23:24-30.
66. Rawls WE, Campione-Piccardo J. Epidemiology of herpes simplex virus type 1 and 2. In: Nahmias A, Dowdle W, Schinazi R, eds. The Human Herpesviruses: An Interdiscipinary Perspective. Amsterdam: Elsevier/North-Holland; 1981:137-152.
67. Bader C, Crumpacker CS, Schnipper LE, et al. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis. 1978;138:897-905.
68. Black FL, Hierholzer WJ, Pinheiro F, et al. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol. 1974;100:230-250.
69. Nahmias AJ, Josey WE, Naib ZM, et al. Antibodies to Herpesvirus hominis type 1 and 1 in humans. I. Patients with genital herpetic infections. Am J Epidemiol. 1970;91:539-546.
70. Nahmias AJ, Josey WE, Naib ZM, et al. Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Am J Epidemiol. 1970;91:547-552.
71. Rawls WE, Tompkins WA, Melnick JL. The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol. 1969;89:547-554.
72. Sawanabori S. Acquisition of herpes simplex virus infection in Japan. Acta Paediatr Jpn Overseas Ed. 1973;15:16.
73. Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of herpesvirus group. Am J Epidemiol. 1971;94:496-507.
74. Gibson JJ, Hornung CA, Alexander GR, et al. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis. 1990;162:306-312.
75. Evans AS, Dick EC. Acute pharyngitis and tonsillitis in University of Wisconsin students. JAMA. 1964;190:699-708.
76. Crespi CM, Cumberland WG, Wald A, et al. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sex Transm Infect. 2007;83(5):359-364.
77. Lee AJ, Ashkar AA. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development. Curr Opin Infect Dis. 2012;25(1):92-99.
78. Sacks SL, Griffiths PD, Corey L, et al. HSV-2 transmission. Antiviral Res. 2004;63(suppl 1):S27-S35.
79. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol. 2001;153:912-920.
80. Institute of Medicine, Committee on Issues and Priorities for New Vaccine Development. Appendix I: Prospects for immunizing against herpes simplex virus 1 and 2. In: New Vaccine Development Establishing Priorities: Disease of Importance in the United States. Washington, DC: National Academy Press; 1985:280-312.
81. Bernstein D, Stokes-Riner A, Hook E, et al. Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3): 344-351.
82. Ng ABP, Reagin JW, Yen SS. Herpes genitalis-clinical and cytopathologic experience with 256 patients. Obstet Gynecol. 1970;36:645-651.
83. Ekwo E, Wong YW, Myers M. Asymptomatic cervicovaginal shedding of herpes simplex virus. Am J Obstet Gynecol. 1979;134:102-103.
84. Rattray MC, Corey L, Reeves WC, et al. Recurrent genital herpes among women: symptomatic versus asymptomatic viral shedding. Br J Vener Dis. 1978;54:262-265.
85. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012;366(1):34-43.
86. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342(12):844-850.
87. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45-52.
88. Adam E, Kaufman RH, Mirkovic RR, et al. Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis. Obstet Gynecol. 1979;54:171-173.
89. Becker WB. The epidemiology of herpesvirus infection in three racial communities in Cape Town. S Afr Med J. 1966;40:109-111.
90. International Herpes Management Forum. Strategies for interrupting the transmission of genital and neonatal HSV infection. Herpes. 2004;11(suppl 3):129A-186A.
91. Rawls WE, Adam E, Melnick JL. Geographical variation in the association of antibodies to herpesvirus type 2 and carcinoma of the cervix. In: Biggs PM, de The G, Payne LN, eds. Oncogenesis and Herpesviruses. Lyon, France: Scientific Publication II, International Agency for Research on Cancer; 1972:424-427.
92. Rawls WE, Gardner HL. Herpes genitalis: venereal aspects. Clin Obstet Gynecol. 1972;15:912-918.
93. Rawls WE, Garfield CH, Seth P, et al. Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer. Cancer Res. 1976;36:829-835.
94. Rawls WE, Gardner HL, Flanders RW, et al. Genital herpes in two social groups. Am J Obstet Gynecol. 1971;110:682-689.
95. Chang TW, Fiumara NJ, Weinstein L. Genital herpes: some clinical and laboratory observations. JAMA. 1974;229:544-545.
96. Reeves WC, Corey L, Adams HG, et al. Risk of recurrence after first episodes of genital herpes: relation to HSV type and antibody response. N Engl J Med. 1981;305:315-319.
97. Choi NW, Shettigara PT, Abu-Zeid HA, et al. Herpesvirus infection and cervical anaplasia: a seroepidemiological study. Int J Cancer. 1977;19:167-171.
98. Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316:1444-1449.
99. Corey L, Ashley R, Benedetti J, et al. The effect of prior HSV-1 infection on the subsequent natural history of genital HSV-2. Presented at: 28th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 23-26, 1988; Los Angeles, California.
100. Longson M. The general nature of viral encephalitis in the United Kingdom. In: Ellis LS, ed. Viral Diseases of the Central Nervous System. London: Bailliere Tindall; 1984:19-31.
101. Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: a randomized multicentre study in consecutive Swedish patients. Lancet. 1984;2:707-711.
102. Whitley RJ, Soong SJ, Linneman C Jr, et al. Herpes simplex encephalitis. Clinical assessment. JAMA. 1982;247(3):317-320.
103. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis. 2002;35:175-282.
104. Boston Interhospital Virus Study Group and the NIAID Sponsored Cooperative Antiviral Clinical Study. Failure of high dose 5-deoxyuridine in the therapy of herpes simplex virus encephalitis: evidence of unacceptable toxicity. N Engl J Med. 1975;292:600-603.
105. Longson M. Le defi des encephalitis herpetiques. Ann Microbiol (Paris). 1979;130:5.
106. Longson MM, Bailey AS, Klapper P. Herpes encephalitis. In: Waterson AP, ed. Recent Advances in Clinical Virology. New York: Churchill Livingstone; 1980:147-157.
107. Whitley RJ, Soong S-J, Dolin R, et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977;297:289-294.
108. Whitley RJ, Soong S-J, Hirsch MS, et al. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981;304: 313-318.
109. International Herpes Management Forum. Herpesvirus infections of the central nervous system. Herpes. 2004;11(suppl 2):47A-120A.
110. Demaerel P, Wilms G, Robberecht W, et al. MRI of herpes simplex encephalitis. Neuroradiology. 1992;34:490-493.
111. Schlesinger Y, Buller RS, Brunstrom JE, et al. Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr. 1995;126:234-241.
112. Sener RN. Diffusion MRI in Rasmussen's encephalitis, herpes simplex encephalitis, and bacterial meningoencephalitis. Comput Med Imaging Graph. 2002;26(5):327-332.
113. Sener RN. Herpes simplex encephalitis: diffusion MR imaging findings. Comput Med Imaging Graph. 2001;25:391-397.
114. Chien LT, Boehm RM, Robinson H, et al. Characteristic early electroencephalographic changes in herpes simplex encephalitis. Arch Neurol. 1977;34:361-364.
115. Miller JHD, Coey A. The EEG in necrotizing encephalitis. Electroencephalogr Clin Neurophysiol. 1959;2:582-585.
116. Radermecker J. Systematique its electrocencephalographic des encephalitis it encephalopathies. Electroencephalography. 1956;8(suppl 5):1-243.
117. Smith JB, Westmoreland BF, Reagan TJ, et al. A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc. 1975;50:469-474.
118. Upton A, Grumpert J. Electroencephalography in diagnosis of herpes simplex encephalitis. Lancet. 1970;1:650-652.
119. Enzmann DR, Ransom B, Norman D. Computed tomography of herpes simplex encephalitis. Radiology. 1978;129:419-425.
120. Zimmerman RD, Russell EJ, Leeds NE, et al. CT in the early diagnosis of herpes simplex encephalitis. Am J Roentgenol. 1980;134:61-66.
121. Rowley A, Lakeman F, Whitley R, et al. Rapid detection of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990;335:440-441.
122. Aurelius E, Johansson B, Skoldenberg B, et al. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet. 1991;337(8735):189-192.
123. Aurelius E, Johansson B, Skoldenberg B, et al. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol. 1993;39:179-186.
124. Puchhammer-Stockl E, Heinz FX, Kundi M, et al. Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol. 1993;31:146-148.
125. Shoji H, Koga M, Kusuhara T, et al. Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringet hybridization of PCR-amplified DNAs. J Neurol. 1994;241:526-530.
126. Sakrauski A, Weber B, Kessler HH, et al. Comparison of two hybridization assays for the rapid detection of PCR amplified HSV genome sequences from cerebrospinal fluid. J Virol Methods. 1994;50:175-184.
127. Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain biopsied patients and correlation with disease. J Infect Dis. 1995;172:857-863.
128. Whitley RJ, Cobbs CG, Alford CA Jr, et al. Diseases that mimic herpes simplex encephalitis: diagnosis, presentation and outcome. JAMA. 1989;262:234-239.
129. Kim C, Yoon YH. Unilateral acute retinal necrosis occurring 2 years after herpes simplex type 1 encephalitis. Ophthalmic Surg Lasers. 2002;33:250-252.
130. Whitley RJ, Alford CA Jr, Hirsch MS, et al. Vidarabine versus acyclovir therapy of herpes simplex encephalitis. N Engl J Med. 1986;314:144-149.
131. Davis LE, McLaren LE. Relapsing herpes simplex encephalitis following antiviral therapy. Ann Neurol. 1983;13:192-195.
132. Dix RD, Baringer JR, Panitch HS, et al. Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol. 1983;13:196-200.
133. Wang HS, Kuo MF, Huang SC, et al. Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol. 1994;11:341-345.
134. VanLandingham KE, Marsteller HB, Ross GW, et al. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA. 1988;259:1051-1053.
135. Zuelzer WW, Wolf W, Stulbery CS. Herpes simplex virus as the cause of fulminating visceral disease and hepatitis in infancy. Am J Dis Child. 1952;83:421-439.
136. Whitley RJ. Herpes simplex virus infections of the central nervous system in children. Semin Neurol. 1982;2:87-97.
137. Florman AL, Gershon AA, Blackett RP, et al. Intrauterine infection with herpes simplex virus: resultant congenital malformation. JAMA. 1973;225:129-132.
138. Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infections. J Pediatr. 1987;110:97-101.
139. South MA, Tompkins WA, Morris CR, et al. Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr. 1969;75:13-18.
140. Gutierrez K, Whitley RJ, Arvin A. Herpes simplex virus infections. In: Remington JS, Klein JO, Wilson CB, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: Elsevier; 2010.
141. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. I. Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985;313:1270-1274.
142. Johnson RE, Nahmias AJ, Magder LS, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321:7-12.
143. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337: 1105-1111.
144. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann Intern Med. 1983;98:958-972.
145. Prober CG, Sullender WM, Yasukawa LL, et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med. 1987;316:240-244.
146. Yeager AS, Arvin AM, Urbani LJ, et al. Relationship of antibody to outcome in neonatal herpes simplex infections. Infect Immun. 1980;29:532-538.
147. Brown ZA, Wald A, Morrow RM, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203-209.
148. Kaye EM, Dooling EC. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology. 1981;31:1045-1047.
149. Parvey LS, Chien LT. Neonatal herpes simplex virus infection introduced by fetal monitor scalp electrode. Pediatrics. 1980;65:1150-1153.
150. Kohl S, West MS, Prober CG, et al. Neonatal antibody-dependent cellular cytoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J Infect Dis. 1989;160: 770-776.
151. Dunkle LM, Schmidt RR, O'Connor DM. Neonatal herpes simplex infection possibly acquired via maternal breast milk. Pediatrics. 1979;63: 250-251.
152. Sullivan-Bolyai JZ, Fife KH, Jacobs RF, et al. Disseminated neonatal herpes simplex virus type 1 from a maternal breast lesion. Pediatrics. 1983;71:455-457.
153. Yeager AS, Ashley RL, Corey L. Transmission of herpes simplex virus from father to neonate. J Pediatr. 1983;103:905-907.
154. Douglas J, Schmidt O, Corey L. Acquisition of neonatal HSV-1 infection from a paternal source contact. J Pediatr. 1983;103:908-910.
155. Linnemann CC Jr, Buchman TG, Light IJ, et al. Transmission of herpes simplex virus type-1 in a nursery for the newborn: identification of viral isolates by D.N.A. "fingerprinting." Lancet. 1978;1:964-966.
156. Light IJ. Postnatal acquisition of herpes simplex virus by the newborn infant: a review of the literature. Pediatrics. 1979;63:480-482.
157. Hammerberg O, Watts J, Chernesky M, et al. An outbreak of herpes simplex virus type 1 in an intensive care nursery. Pediatr Infect Dis. 1983;2:290-294.
158. Centers for Disease Control and Prevention. Neonatal herpes simplex virus infection following Jewish ritual circumcisions that included direct orogenital suction-New York City, 2000-2011. MMWR Morb Mortal Wkly Rep. 2012;61(22):405-409.
159. Flewett TH, Parker RGF, Philip WM. Acute hepatitis due to herpes simplex virus in an adult. J Clin Pathol. 1969;22:60-66.
160. Anderson JM, Nicholls MWN. Herpes encephalitis in pregnancy. Br Med J. 1972;1:632.
161. Goyette RE, Donowho EM, Hieger LR, et al. Fulminant herpesvirus hominis hepatitis during pregnancy. Obstet Gynecol. 1974;43:191-196.
162. Young EJ, Killam AP, Greene JF. Disseminated herpesvirus infection associated with primary genital herpes in pregnancy. JAMA. 1976;235: 2731-2733.
163. Nahmias AJ, Josey WE, Naib ZM, et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 1971;110:825-836.
164. Vontver LA, Hickok DE, Brown Z, et al. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol. 1982;143:75-84.
165. Tejani N, Klein SW, Kaplan M. Subclinical herpes simplex genitalis infections in the perinatal period. Am J Obstet Gynecol. 1979;135:547.
166. Bolognese RJ, Corson SL, Fuccillo DA, et al. Herpesvirus hominis type-2 infections in asymptomatic pregnant women. Obstet Gynecol. 1976;48:507-510.
167. Harger JH, Pazin GJ, Armstrong JA, et al. Characteristics and management of pregnancy in women with genital herpes simplex virus infection. Am J Obstet Gynecol. 1983;145:784-791.
168. Jeansson S, Molin L. Genital herpesvirus hominis infection. A veneral disease. Lancet. 1970;1:1064-1065.
169. Whitley RJ, Nahmias AJ, Visitine AM, et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980;66: 489-494.
170. Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics. 1984;73:188-193.
171. Arvin AM, Yeager AS, Bruhn FW, et al. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr. 1982;100:715-721.
172. Mizrahi EM, Tharp BR. A unique electroencephalogram pattern in neonatal herpes simplex virus encephalitis. Neurology. 1981;31:164.
173. Whitley RJ, Nahmias AJ, Soong S-J, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980;66:495-501.
174. Guttman LT, Wilfert CM, Eppes S. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration. J Infect Dis. 1986;154:415-421.
175. Nahmias AJ, Visitine A, Caldwell A, et al. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol. 1976;21:100-105.
176. Nahmias A, Hagler W. Ocular manifestations of herpes simplex in the newborn. Int Ophthalmol Clin. 1972;12:191-213.
177. Reested P, Hansen B. Chorioretinitis of the newborn with herpes simplex type 1: Report of a case. Acta Ophthalmol. 1979;57:1096-2100.
178. Cibis A, Burde RM. Herpes simplex virus induced congenital cataracts. Arch Ophthalmol. 1971;85:220-223.
179. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1996;174(6):1162-1167.
180. Ware JR Jr, Maruish ME, eds. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 1999.
181. International Herpes Management Forum. Herpes. 2002;9:31-55.
182. Hardy DA, Arvin AM, Yasukawa LL, et al. Use of polymerase chain for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women in delivery. J Infect Dis. 1990;162:1031-1035.
183. Stone KM, Brooks CA, Guinan ME, et al. National surveillance for neonatal herpes simplex virus infection. Sex Trans Dis. 1989;16:152-156.
184. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230-238.
185. Whitley RJ, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324:444-449.
186. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2): 223-229.
187. Whitley RJ, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med. 1991;324:450-454.
188. Kimberlin DW, Whitley RJ, Wan W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284-1292.